Centene Corp (NYSE:CNC) shares plunged nearly 40% after the company withdrew its full-year 2025 financial guidance, citing a projected $1.8 billion shortfall in risk adjustment revenue, translating to a $2.75 per share reduction in adjusted earnings. This significant revision is attributed to higher-than-expected costs and weak growth within its Affordable Care Act marketplace business, driven by a sicker-than-anticipated insured population and slower overall market expansion.
Centene Corporation (NYSE:CNC) is experiencing a severe repricing after withdrawing its full-year 2025 financial guidance, triggering a nearly 40% decline in its share price to approximately $34. The decision stems from a significant operational and financial setback within its core Affordable Care Act (ACA) marketplace business. A preliminary analysis by the actuarial firm Wakely projects a $1.8 billion shortfall in risk adjustment revenue, which directly translates to a material $2.75 per share reduction in adjusted earnings. This adverse development is attributed to two primary factors: a sicker-than-anticipated insured population, leading to higher morbidity and costs, and weaker-than-expected overall market growth. The issue is systemic to Centene's marketplace operations, affecting business in 22 of its 29 states and impacting roughly 72% of its marketplace membership, indicating a widespread challenge rather than a localized one.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
extremely negative
Sentiment Score
-0.90
Ticker Sentiment